Mechanism-aligned ketamine therapy for treatment-resistant depression: a 2026 update—toward an integrative mechanistic framework for clinical translation
Ketamine is increasingly understood to exert therapeutic effects through multiple interacting biological and experiential processes rather than a single pharmacological mechanism. In treatment-resistant depression (TRD), where conventional monoaminergic antidepressants often fail, ketamine’s rapid effects are thought to emerge through the coordinated, temporally structured engagement of five…
Read original article on Frontiers in Psychiatry | New and Recent Articles →